Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 77, Issue 5-6, 2007, Pages 251-261

  Rapoport, Stanley I ^a   Rao, Jagadeesh S ^a   Igarashi, Miki ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; LINOLENIC ACID; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ARTICLE; BRAIN METABOLISM; CATALYSIS; DIET; DOWN REGULATION; LIPID STORAGE; LIPOGENESIS; LIVER; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, ESSENTIAL; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; HUMANS; LIVER; MODELS, BIOLOGICAL; PHOSPHOLIPIDS; RATS;

RATTUS; VERTEBRATA;

EID: 36749082536     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.10.023     Document Type: Article

References (72)

1. DeGeorge J.J., Nariai T., Yamazaki S., Williams W.M., and Rapoport S.I. Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats. J. Neurochem. 56 1 (1991) 352-355
2. Axelrod J., Burch R.M., and Jelsema C.L. Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers. Trends Neurosci. 11 3 (1988) 117-123
3. Rapoport S.I. In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling. J. Mol. Neurosci. 16 (2001) 243-261
4. Contreras M.A., and Rapoport S.I. Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues. Curr. Opin. Lipidol. 13 (2002) 267-272
5. Youdim K.A., Martin A., and Joseph J.A. Essential fatty acids and the brain: possible health implications. Int. J. Dev. Neurosci. 18 4-5 (2000) 383-399
6. Innis S.M. The role of dietary n-6 and n-3 fatty acids in the developing brain. Dev. Neurosci. 22 5-6 (2000) 474-480
7. Holman R.T. Control of polyunsaturated acids in tissue lipids. J. Am. Coll. Nutr. 5 2 (1986) 183-211
8. Bourre J.M., Francois M., Youyou A., et al. The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr. 119 12 (1989) 1880-1892
9. Conquer J.A., Tierney M.C., Zecevic J., Bettger W.J., and Fisher R.H. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35 12 (2000) 1305-1312
10. Noaghiul S., and Hibbeln J.R. Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am. J. Psychiatry 160 12 (2003) 2222-2227
11. Pawlosky R.J., and Salem Jr. N. Alcohol consumption in rhesus monkeys depletes tissues of polyunsaturated fatty acids and alters essential fatty acid metabolism. Alcohol Clin. Exp. Res. 23 (1999) 311-317
12. Stoll A.L., Severus W.E., Freeman M.P., et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch. Gen. Psychiatry 56 (1999) 407-412
13. Kris-Etherton P.M., Taylor D.S., Yu-Poth S., et al. Polyunsaturated fatty acids in the food chain in the United States. Am. J. Clin. Nutr. 71 1 Suppl. (2000) 179S-188S
14. British Nutrition Foundation (Ed.), Unsaturated Fatty Acids Nutritional and Physiological Significance: The Report of the British Nutrition Foundation's Task Force. Chapman and Hall, New York, 1992.
15. Simopoulos A.P. Commentary on the workshop statement. Essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 63 3 (2000) 123-124
16. Scientific Review Committee. Minister of National Health and Welfare (1999), Canadian Government Publishing Centre, Ottawa, Canada p. 208
17. Bourre J.M., and Piciotti M. Delta-6 desaturation of alpha-linolenic acid in brain and liver during development and aging in the mouse. Neurosci. Lett. 141 1 (1992) 65-68
18. Burke P.A., Ling P.R., Forse R.A., Lewis D.W., Jenkins R., and Bistrian B.R. Sites of conditional essential fatty acid deficiency in end stage liver disease. J. Parenter. Enteral. Nutr. 25 4 (2001) 188-193
19. Scott B.L., and Bazan N.G. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc. Natl. Acad. Sci. USA 86 8 (1989) 2903-2907
20. Igarashi M., Demar Jr. J.C., Ma K., Chang L., Bell J.M., and Rapoport S.I. Rate of synthesis of docosahexaenoic acid from alpha-linolenic acid by rat brain is not altered by dietary N-3 polyunsaturated fatty acid deprivation. J. Lipid Res. 48 (2007) 1150-1158
21. Igarashi M., DeMar Jr. J.C., Ma K., Chang L., Bell J.M., and Rapoport S.I. Upregulated liver conversion of alpha-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet. J. Lipid Res. 48 1 (2007) 152-164
22. Jones C.R., Arai T., Bell J.M., and Rapoport S.I. Preferential in vivo incorporation of [3H]arachidonic acid from blood in rat brain synaptosomal fractions before and after cholinergic stimulation. J. Neurochem. 67 2 (1996) 822-829
23. Bayon Y., Hernandez M., Alonso A., et al. Cytosolic phospholipase A2 is coupled to muscarinic receptors in the human astrocytoma cell line 1321N1: characterization of the transducing mechanism. Biochem. J. 323 (1997) 281-287
24. Clark J.D., Lin L.L., Kriz R.W., et al. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 65 6 (1991) 1043-1051
25. Strokin M., Sergeeva M., and Reiser G. Prostaglandin synthesis in rat brain astrocytes is under the control of the n-3 docosahexaenoic acid, released by group VIB calcium-independent phospholipase A(2). J. Neurochem. (2007)
26. Dennis E.A. Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269 (1994) 13057-13060
27. Rapoport S.I. In vivo approaches to quantifying and imaging brain arachidonic and docosahexaenoic acid metabolism. J. Pediatr. 143 4 Suppl. (2003) S26-S34
28. Purdon A.D., and Rapoport S.I. In: Gibson G., and Dienel G. (Eds). Neural Energy Utilization: Handbook of Neurochemistry and Molecular Biology (2007), Springer, New York 401-427
29. Horrocks L.A., and Farooqui A.A. Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot. Essent. Fatty Acids 70 4 (2004) 361-372
30. Sun G.Y., and MacQuarrie R.A. Deacylation-reacylation of arachidonoyl groups in cerebral phospholipids. Ann. N.Y. Acad. Sci. 559 (1989) 37-55
31. Robinson P.J., Noronha J., DeGeorge J.J., Freed L.M., Nariai T., and Rapoport S.I. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res. Brain Res. Rev. 17 (1992) 187-214
32. Fitzpatrick F.A., and Soberman R. Regulated formation of eicosanoids. J. Clin. Invest. 107 (2001) 1347-1351
33. Sugiura T., Kondo S., Sukagawa A., et al. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine. Eur. J. Biochem. 240 1 (1996) 53-62
34. Shimizu T., and Wolfe L.S. Arachidonic acid cascade and signal transduction. J. Neurochem. 55 1 (1990) 1-15
35. Rapoport S.I., Chang M.C., and Spector A.A. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res. 42 5 (2001) 678-685
36. Lands W.E.M., and Crawford C.G. In: Martonosi A. (Ed). The Enzymes of Biological Membranes (1976), Plenum, New York 3-85
37. Jones C.R., Arai T., and Rapoport S.I. Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse. Neurochem. Res. 22 (1997) 663-670
38. Demar Jr. J.C., Ma K., Chang L., Bell J.M., and Rapoport S.I. Alpha-linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J. Neurochem. 94 4 (2005) 1063-1076
39. DeMar Jr. J.C., Lee H.J., Ma K., et al. Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim. Biophys. Acta 1761 9 (2006) 1050-1059
40. Purdon D., Arai T., and Rapoport S. No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat. J. Lipid Res. 38 3 (1997) 526-530
41. 11C]-arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography. Brain Res. 755 (1997) 74-83
42. Contreras M.A., Greiner R.S., Chang M.C., Myers C.S., Salem Jr. N., and Rapoport S.I. Nutritional deprivation of alpha-linolenic acid decreases but does not abolish turnover and availability of unacylated docosahexaenoic acid and docosahexaenoyl-CoA in rat brain. J. Neurochem. 75 6 (2000) 2392-2400
43. Contreras M.A., Chang M.C., Rosenberger T.A., et al. Chronic nutritional deprivation of n-3 alpha-linolenic acid does not affect n-6 arachidonic acid recycling within brain phospholipids of awake rats. J. Neurochem. 79 5 (2001) 1090-1099
44. Chang M.C., Grange E., Rabin O., Bell J.M., Allen D.D., and Rapoport S.I. Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci. Lett. 220 (1996) 171-174 Erratum in: Neurosci Lett 1997 31, 222:141
45. Basselin M., Villacreses N.E., Lee H.J., Bell J.M., and Rapoport S.I. Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation. J. Neurochem. 102 (2007) 761-772
46. DeMar Jr. J.C., Ma K., Bell J.M., and Rapoport S.I. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J. Neurochem. 91 5 (2004) 1125-1137
47. Shetty H.U., Smith Q.R., Washizaki K., Rapoport S.I., and Purdon A.D. Identification of two molecular species of rat brain phosphatidylcholine that rapidly incorporate and turn over arachidonic acid in vivo. J. Neurochem. 67 (1996) 1702-1710
48. Giovacchini G., Chang M.C., Channing M.A., et al. Brain incorporation of [11C]arachidonic acid in young healthy humans measured with positron emission tomography. J. Cereb. Blood Flow Metab. 22 12 (2002) 1453-1462
49. Giovacchini G., Lerner A., Toczek M.T., et al. Brain incorporation of 11C-arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction. J. Nucl. Med. 45 9 (2004) 1471-1479
50. Esposito G., Giovacchini G., Der M., et al. Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomography. Neuroimage 34 4 (2007) 1342-1351
51. Channing M.A., and Simpson N. Radiosynthesis of 1-[11C]polyhomoallylic fatty acids. J. Labeled Compd. Radiopharmacol. 33 (1993) 541-546
52. Martinez M. Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation?. Neurology 40 8 (1990) 1292-1298
53. Food and Nutrition Board. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids (Macronutrients) (2005), National Academies Press, Washington, DC
54. Igarashi M., Ma K., Chang L., Bell J.M., Rapoport S.I., and Demar Jr. J.C. Low liver conversion rate of alpha-linolenic to docosahexaenoic acid in awake rats on a high-docosahexaenoate-containing diet. J. Lipid Res. 47 8 (2006) 1812-1822
55. Demar Jr. J.C., Ma K., Bell J.M., Igarashi M., Greenstein D., and Rapoport S.I. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J. Lipid Res. 47 1 (2006) 172-180
56. Igarashi M., Ma K., Chang L., Bell J.M., and Rapoport S.I. Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain. J. Lipid Res. (2007)
57. Rao J.S., Ertley R.N., DeMar Jr. J.C., Rapoport S.I., Bazinet R.P., and Lee H.J. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol. Psychiatry 12 2 (2007) 151-157
58. Murakami M., Kambe T., Shimbara S., and Kudo I. Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J. Biol. Chem. 274 5 (1999) 3103-3115
59. Bosetti F., and Weerasinghe G.R. The expression of brain cyclooxygenase-2 is down-regulated in the cytosolic phospholipase A2 knockout mouse. J. Neurochem. 87 6 (2003) 1471-1477
60. Bazan N.G., Aveldano de Caldironi M.I., and Rodriguez de Turco E.B. Rapid release of free arachidonic acid in the central nervous system due to stimulation. Prog. Lipid Res. 20 (1981) 523-529
61. Choi S.H., Langenbach R., and Bosetti F. Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappaB pathway and downstream enzymes involved in prostaglandin biosynthesis. J. Neurochem. 98 (2006) 801-811
62. Rosenberger T.A., Villacreses N.E., Hovda J.T., et al. Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J. Neurochem. 88 5 (2004) 1168-1178
63. Basselin M., Chang L., Bell J.M., and Rapoport S.I. Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology 31 8 (2006) 1659-1674
64. Rabin O., Chang M.C., Grange E., et al. Selective acceleration of arachidonic acid reincorporation into brain membrane phospholipid following transient ischemia in awake gerbil. J. Neurochem. 70 (1998) 325-334
65. Krystal J.H., Sanacora G., Blumberg H., et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol. Psychiatry 7 Suppl. 1 (2002) S71-S80
66. McGeer E.G., and McGeer P.L. Inflammatory processes in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 5 (2003) 741-749
67. Chao M.V., Rajagopal R., and Lee F.S. Neurotrophin signalling in health and disease. Clin. Sci. (Lond.) 110 2 (2006) 167-173
68. Rao J.S., Ertley R.N., Lee H.J., et al. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol. Psychiatry 12 1 (2007) 36-46
69. Barco A., Pittenger C., and Kandel E.R. CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects. Expert Opin. Ther. Targets 7 1 (2003) 101-114
70. 3H]arachidonic acid in murine fibrosarcoma cells measured by electron microscope autoradiography. J. Cell Biol. 101 2 (1985) 573-581
71. Chang M.C., Bell J.M., Purdon A.D., Chikhale E.G., and Grange E. Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment. Neurochem. Res. 24 3 (1999) 399-406
72. Igarashi M., DeMar Jr. J.C., Ma K., Chang L., Bell J.M., and Rapoport S.I. Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J. Lipid Res. 48 5 (2007) 1150-1158